Abstract:A series of 4‐(arylsulphonylaminocarbonylamino)‐3,4‐dihydro‐2,2‐dimethyl‐2 H‐1‐benzo‐pyran derivatives were prepared and evaluated as potential ATP‐sensitive potassium‐channel activators.
Pharmacological studies showed that some compounds expressed vasodilator efficacy on vascular smooth muscle. The compounds had no inhibitory activity on insulin secretion from pancreatic β‐cells.
“…Convenient starting materials for the synthesis of the original R/ S -3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminocarbonylamino)-2 H -1-benzopyrans ( 13 − 42 ) are R/S -4-amino-3,4-dihydro-2,2-dimethyl-6-fluoro-2 H -1-benzopyran ( 12a ), R/ S -4-amino-6-chloro-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12b ), and R/ S -4-amino-6-bromo-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12c ). These compounds were prepared according to the methods previously reported. , …”
Section: Methodsmentioning
confidence: 99%
“…These compounds were prepared according to the methods previously reported. 21,22 R/S-3,4-Dihydro-2,2-dimethyl-6-fluoro-4-(phenylaminocarbonylamino)-2H-1-benzopyran (13). Phenyl isocyanate (0.26 mL, 2.4 mmol) was added to a solution of 12a 22 (0.4 g, 2 mmol) in…”
Section: Methodsmentioning
confidence: 99%
“…Chemistry. The key intermediates for the synthesis of compounds 13 − 42 , R/ S -4-amino-3,4-dihydro-2,2-dimethyl-6-fluoro-2 H -1-benzopyran ( 12a ), R/ S -4-amino-6-chloro-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12b ), and R/ S -4-amino-6-bromo-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12c ) were obtained, as described previously, in six steps starting from the appropriate p -halogenophenols , (Scheme ). …”
Section: Introductionmentioning
confidence: 99%
“…Chemistry. The key intermediates for the synthesis of compounds 13-42, R/S-4-amino-3,4-dihydro-2,2-dimethyl-6fluoro-2H-1-benzopyran (12a), R/S-4-amino-6-chloro-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (12b), and R/S-4-amino-6bromo-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (12c) were obtained, as described previously, in six steps starting from the appropriate p-halogenophenols 21,22 (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%
“…Treatment of acetophenones 8a-c with acetone in the presence of pyrrolidine led to chromanone intermediates 9a-c, which were reduced to chromanols 10a-c with sodium borohydride in methanol. The 4-acetylaminobenzopyrans 11a-c were prepared by the Ritter reaction 22 from chromanols 10a-c. This reaction occurred in acetonitrile supplemented with concentrated sulfuric acid.…”
In the search of a novel series of benzopyrans structurally related to (+/-)-cromakalim and acting as pancreatic beta-cell potassium channel openers, several R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans with or without a substituent on the phenyl ring in the 4-position were synthesized. Their activity on rat-insulin-secreting cells and rat aorta rings was compared to that of the K(ATP) channel activators (+/-)-cromakalim, diazoxide, (+/-)-pinacidil, and compound 4. Structure-activity relationships indicated that the most pronounced inhibitory activity on the pancreatic tissue was obtained by introducing a meta- or para-electron-withdrawing group (a chlorine atom) on the C-4 phenyl ring (drugs 37-42). Such molecules, unlike the parent compound (+/-)-cromakalim, also exhibited a high selectivity for the pancreatic tissue versus the vascular tissue. Radioisotopic and electrophysiological investigations performed with R/S-6-chloro-4-(3-chlorophenylaminocarbonylamino)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (38) confirmed that the drug activated pancreatic KATP channels.
“…Convenient starting materials for the synthesis of the original R/ S -3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminocarbonylamino)-2 H -1-benzopyrans ( 13 − 42 ) are R/S -4-amino-3,4-dihydro-2,2-dimethyl-6-fluoro-2 H -1-benzopyran ( 12a ), R/ S -4-amino-6-chloro-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12b ), and R/ S -4-amino-6-bromo-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12c ). These compounds were prepared according to the methods previously reported. , …”
Section: Methodsmentioning
confidence: 99%
“…These compounds were prepared according to the methods previously reported. 21,22 R/S-3,4-Dihydro-2,2-dimethyl-6-fluoro-4-(phenylaminocarbonylamino)-2H-1-benzopyran (13). Phenyl isocyanate (0.26 mL, 2.4 mmol) was added to a solution of 12a 22 (0.4 g, 2 mmol) in…”
Section: Methodsmentioning
confidence: 99%
“…Chemistry. The key intermediates for the synthesis of compounds 13 − 42 , R/ S -4-amino-3,4-dihydro-2,2-dimethyl-6-fluoro-2 H -1-benzopyran ( 12a ), R/ S -4-amino-6-chloro-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12b ), and R/ S -4-amino-6-bromo-3,4-dihydro-2,2-dimethyl-2 H -1-benzopyran ( 12c ) were obtained, as described previously, in six steps starting from the appropriate p -halogenophenols , (Scheme ). …”
Section: Introductionmentioning
confidence: 99%
“…Chemistry. The key intermediates for the synthesis of compounds 13-42, R/S-4-amino-3,4-dihydro-2,2-dimethyl-6fluoro-2H-1-benzopyran (12a), R/S-4-amino-6-chloro-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (12b), and R/S-4-amino-6bromo-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (12c) were obtained, as described previously, in six steps starting from the appropriate p-halogenophenols 21,22 (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%
“…Treatment of acetophenones 8a-c with acetone in the presence of pyrrolidine led to chromanone intermediates 9a-c, which were reduced to chromanols 10a-c with sodium borohydride in methanol. The 4-acetylaminobenzopyrans 11a-c were prepared by the Ritter reaction 22 from chromanols 10a-c. This reaction occurred in acetonitrile supplemented with concentrated sulfuric acid.…”
In the search of a novel series of benzopyrans structurally related to (+/-)-cromakalim and acting as pancreatic beta-cell potassium channel openers, several R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans with or without a substituent on the phenyl ring in the 4-position were synthesized. Their activity on rat-insulin-secreting cells and rat aorta rings was compared to that of the K(ATP) channel activators (+/-)-cromakalim, diazoxide, (+/-)-pinacidil, and compound 4. Structure-activity relationships indicated that the most pronounced inhibitory activity on the pancreatic tissue was obtained by introducing a meta- or para-electron-withdrawing group (a chlorine atom) on the C-4 phenyl ring (drugs 37-42). Such molecules, unlike the parent compound (+/-)-cromakalim, also exhibited a high selectivity for the pancreatic tissue versus the vascular tissue. Radioisotopic and electrophysiological investigations performed with R/S-6-chloro-4-(3-chlorophenylaminocarbonylamino)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran (38) confirmed that the drug activated pancreatic KATP channels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.